• OSI-027 CHEMBL3120215 Antineoplastic

    Alternate Names:

    OSI-027
    X7443
    2616AH
    SCHEMBL11971939
    C21H22N6O3.CLH
    71307533
    (Z)-4-(4-AMINO-5-(7-METHOXY-2H-INDOL-2-YLIDENE)-1,5-DIHYDROIMIDAZO[5,1-F][1,2,4]TRIAZIN-7-YL)CYCLOHEXANE-1-CARBOXYLIC ACID
    (1R,4R)-4-[4-AMINO-5-(7-METHOXY-1H-INDOL-2-YL)IMIDAZO[4,3-F][1,2,4]TRIAZIN-7-YL]CYCLOHEXANE-1-CARBOXYLIC ACID
    (1R,4R)-4-(4-AMINO-5-(7-METHOXY-1H-INDOL-2-YL)IMIDAZO[5,1-F][1,2,4]TRIAZIN-7-YL)CYCLOHEXANECARBOXYLIC ACID
    (+/-)-CYCLOHEXANECARBOXYLIC ACID, 4-(4-AMINO-5-(7-METHOXY-1H-INDOL-2-YL)IMIDAZO(5,1-F)(1,2,4)TRIAZIN-7-YL)-, TRANS-
    OSI 027, OSI-027, 936890-98-1
    OSI 027, OSI-027, 936890-98-1
    QC-11756
    HY-10423
    BC638859
    CS-0257
    BCP9001034
    ABP000909
    CYCLOHEXANECARBOXYLIC ACID, 4-(4-AMINO-5-(7-METHOXY-1H-INDOL-2-YL)IMIDAZO(5,1-F)(1,2,4)TRIAZIN-7-YL)-, TRANS-
    MOLPORT-023-293-499
    CHEMBL2132692
    SCHEMBL976796
    SCHEMBL976795
    25MKH1SZ0M
    S2624_SELLECK
    K1146_KINASECHEM
    OSI027, OSI-027
    UNII-25MKH1SZ0M
    936890-98-1
    44224160
    OSI 027
    DCL001095

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    Drug Class Kinase Inhibitors
    Notes catalytic inhibitor
    Notes TORC1/2, catalytic inhibitor
    (3 More Sources)